According to a company press release, Molecular Insight Pharmaceuticals, Inc. presented clinical data earlier today on a development-stage, radiolabeled, small-molecule, molecular imaging pharmaceutical with potential in the diagnosis, staging, and perhaps even the treatment of advanced forms of prostate cancer.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Diagnosis, metastatic, prostate cancer, staging, Treatment, Trofex | 6 Comments »

Search for new and
ongoing trials on the
CTAG PCa web site
